CELC
CelcuityBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
CELC vs peer average
84/100
CELC vs. peer average (B vs. D)
Grade spread
C 3 · D 1 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
ELVN is the first available peer comparator.
A similar-market-cap biotechnology candidate useful only as a broad development-risk and financing comparator; the packet does not establish indication, asset-stage or commercial comparability.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CELC
Celcuity
ELVN
Enliven Therapeutics
Grade
B
F
Momentum
12
89
Value
41
41
Sentiment
88
28
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs ELVN
CELC / ELVN
Grade Position
Above peers
CELC vs. peer average (B vs. D)
84/100
Momentum
12
ELVNValue
41
CELCSentiment
88
CELCRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CELC
ELVN is the first peer returned for this comparison set.

